FDA updates cybersecurity guidance for medical device makers
The Food and Drug Administration Sept. 26 finalized guidance updating the cybersecurity information device makers should submit to its Center for Devices and Radiological Health or Center for Biologics Evaluation and Research for premarket review of devices that have cybersecurity considerations. The recommendations are intended to help manufacturers meet their obligations under section 524B of the Federal Food, Drug, and Cosmetic Act, enacted in December 2022 as part of the Consolidated Appropriations Act of 2023, which defines “cyber device” as one that includes a device or software that can connect to the internet and be vulnerable to cybersecurity threats.
Related News Articles
Headline
The FBI released an alert March 20 warning of a technique used by cyber actors working on behalf of the Iranian government to conduct malicious cyber activity…
Headline
The Cybersecurity and Infrastructure Security Agency March 18 released an alert urging U.S. organizations to harden their endpoint management systems following…
Headline
The Health Sector Coordinating Council Cyber Working Group and Health-ISAC (Information Sharing and Analysis Center) will host a joint cybersecurity event July…
Headline
Stryker, a medical technology company that provides services and products for hospitals, was disrupted globally by a cyberattack, the company announced March…
Headline
The White House issued an executive order March 6 to combat cybercrimes by threat groups. The order highlights how such groups can receive willing or…
Headline
The Administration for Strategic Preparedness and Response has released a new cybersecurity module for organizations to conduct risk assessments. The free…